Senate Bill 776 would amend Florida law to allow certain qualified medical marijuana patients who are at least 21 years old to grow cannabis at home for personal, noncommercial use. Specifically, it authorizes those patients to cultivate up to six flowering cannabis plants at their residence and to buy medical marijuana seeds and clones from a licensed medical marijuana treatment center.
The bill also requires patients who grow cannabis to secure the plants so unauthorized persons cannot access them. It ties consumption of homegrown cannabis to the existing medical marijuana limitations in state law and makes clear that selling patient-grown cannabis, or growing beyond the bill’s limits, would remain subject to criminal penalties under chapter 893. The bill would take effect July 1, 2026.
Impact
If enacted, the bill would create a new statutory exception within Florida’s local regulation of vegetable gardens law, effectively establishing a limited home-cultivation right for qualifying medical marijuana patients. It would expand patient access by allowing purchase of seeds and clones from licensed medical marijuana treatment centers and would add new compliance obligations related to secure storage and noncommercial use. At the same time, it preserves existing restrictions on medical marijuana use and maintains criminal penalties for unauthorized sales or cultivation beyond the permitted limits.
Sentiment
Based on the bill text and the absence of recorded committee debate or votes in the provided materials, the measure appears to be framed as a narrowly tailored expansion of patient rights rather than a broader marijuana legalization proposal. Its structure suggests an effort to balance access for qualified patients with safeguards against diversion and unregulated commercial activity. No formal sentiment from committee discussion or voting history is available in the provided record.
Contention
The main points of contention likely center on whether Florida should permit home cultivation at all, even for medical marijuana patients, and whether six plants is an appropriate limit. Supporters would likely emphasize patient access, affordability, and autonomy, while opponents may raise concerns about diversion, enforcement, and the difficulty of ensuring plants are secured and used only for medical purposes. The bill’s explicit penalties for sales and over-limit cultivation indicate that those issues are central to the legislation’s design.